Clinical Trial Update: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

This Phase 1 study evaluated the safety, pharmacokinetics, and pharmacodynamics of JNJ-42756493 in adults with advanced or refractory solid tumors or lymphoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Lymphoma

Drugs mentioned

• JNJ-42756493

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Tumor or Lymphoma | Phase 1 | Status: COMPLETED